Menorrhagia or heavy menstrual bleeding results in a reduced quality of life and significant socioeconomic burden to affected women worldwide. So far, multiple treatment options exist that offer different potential for symptom control at highly variable initial cost. However, the relative value of these treatment options is unknown.
In this regard, a recent study investigated the relative cost effectiveness of four treatment options for menorrhagia including: Hysterectomy Resectoscopic endometrial ablation Non-resectoscopic endometrial ablation Levonorgestrel-releasing intrauterine system (LNG-IUS) Comparing all trade-offs associated with four possible treatments of heavy menstrual bleeding, the clinical findings of the study suggested that- LNG-IUS was superior to both hysterectomy and endometrial ablation in terms of cost and quality of life. Hysterectomy was associated with superior…
